Primary tabs
Dr Scott Henry - Senior Vice President of Preclinical Development, Ionis Pharmaceuticals
Masterclass title: Understanding the Mechanism for Dose - Dependent Thrombocytopenia Associated with 2’MOE Antisense Oligonucleotides
Date:
Wednesday, 22 September, 2021 - 16:00 to 17:00